Vicarious Surgical Inc.
RBOTOTCCIK 1812173HealthcareFiscal year ends Dec 31
Reports and events: 116 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-07-2116:10 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-080011 |
| 2026-06-2417:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-071589 |
| 2026-06-2208:32 ET | DEF 14A | Proxy statementPeriod 2026-07-21 | 0001213900-26-070393 |
| 2026-04-3008:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213900-26-049749 |
| 2026-04-0816:30 ET | 8-K | 5.07 Shareholder vote results | 0001213900-26-041522 |
| 2026-04-0619:01 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001720215-26-000003 |
| 2026-03-2316:30 ET | DEF 14A | Proxy statementPeriod 2026-04-08 | 0001213900-26-032944 |
| 2026-03-0916:17 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-025193 |
| 2026-03-0916:16 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001213900-26-025189 |
| 2026-03-0616:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-024707 |
| 2026-03-0407:00 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-023404 |
| 2026-02-0216:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-010807 |
| 2026-01-0916:53 ET | 8-K | 5.07 Shareholder vote results | 0001213900-26-002973 |
| 2025-12-1616:15 ET | 8-K | 1.01 Entry into a material agreement; 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-122267 |
| 2025-12-1618:16 ET | DEF 14A | Proxy statementPeriod 2026-01-09 | 0001213900-25-121806 |
| 2025-12-0307:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-117558 |
| 2025-11-1217:00 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001213900-25-109320 |
| 2025-11-1216:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-109214 |
| 2025-10-0817:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-097471 |
| 2025-09-2516:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-091651 |
| 2025-09-2317:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-090683 |
| 2025-09-1616:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-25-088203 |
| 2025-09-0806:38 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-085274 |
| 2025-08-1217:00 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001213900-25-075049 |
| 2025-08-1216:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-074974 |
| 2025-07-3116:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-070028 |
| 2025-07-1116:30 ET | 8-K | 3.01 Delisting notice; 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-25-063296 |
| 2025-06-3006:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-059237 |
| 2025-05-1319:47 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-042203 |
| 2025-05-1217:00 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001213900-25-042087 |
| 2025-04-2915:26 ET | DEF 14A | Proxy statementPeriod 2025-06-27 | 0001140361-25-016293 |
| 2025-04-1116:38 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-031124 |
| 2025-03-2416:28 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001013762-25-001611 |
| 2025-03-1717:00 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001213900-25-024588 |
| 2025-03-1716:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-024548 |
| 2025-03-1308:57 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-023441 |
| 2025-02-1816:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-014890 |
| 2025-01-2116:37 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-25-005036 |
| 2024-12-0616:23 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-24-106503 |
| 2024-11-1217:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001213900-24-096886 |
| 2024-11-1216:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-096820 |
| 2024-08-1318:24 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001213900-24-067807 |
| 2024-08-1216:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-067689 |
| 2024-06-1416:05 ET | 8-K | 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-24-052876 |
| 2024-06-1016:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-051236 |
| 2024-05-1316:05 ET | 10-Q/A | Quarterly report, amendedPeriod 2024-03-31 | 0001213900-24-042291 |
| 2024-04-2917:02 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001213900-24-037265 |
| 2024-04-2916:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-037162 |
| 2024-04-2316:14 ET | DEF 14A | Proxy statementPeriod 2024-06-10 | 0001140361-24-021339 |
| 2024-03-0417:22 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001213900-24-019594 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.